3.73
2.75%
+0.10
Handel nachbörslich:
3.73
Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Research and Development |
8.27%
0.982
|
0.907 | 3.027 | 1.215 | 0.545 |
Operating Income/Loss |
2.47%
-2.119
|
-2.068 | -3.923 | -6.429 | -3.912 |
Income/Loss From Continuing Operations Before Tax |
20.27%
0.617
|
0.513 | -4.016 | -7.602 | 0.524 |
Income/Loss From Continuing Operations After Tax |
20.27%
0.617
|
0.513 | -4.016 | -7.602 | 0.524 |
Net Income/Loss
|
20.27%
0.617
|
0.513 | -4.016 | -7.602 | 0.524 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
76.92%
-0.023
|
-0.013 | -0.009 | -0.066 | -0.051 |
Basic Average Shares |
57.65%
3.4366
|
8.1142 | - | 5.5648 | 0.7436 |
Basic Earnings Per Share |
833.33%
0.56
|
0.06 | -0.52 | -1.35 | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):